Lipitor, Atorvastatin

Lipitor, Atorvastatin Newswire (Page 9)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 9)

Results 161 - 180 of 780 in Lipitor, Atorvastatin (generic)

  1. We can do much to hold down medication costsRead the original story w/Photo

    Oct 7, 2014 | Portland Tribune

    Recently, the National Institutes of Health urged physicians to prescribe a water pill, called hydrochlorothiazide, as the initial treatment for hypertension. Despite a large study that showed this water pill was as effective in lowering blood pressure and reducing the risk of heart attacks and heart failure as the more-expensive medications, very few physicians changed their prescribing habits.

    Comment?

  2. Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?Read the original story

    Oct 7, 2014 | The Motley Fool

    Amgen's evolocumab and alirocumab from Sanofi and Regeneron probably won't achieve that level considering they'll compete with generic statins, like Lipitor, or find smaller niches, but they both still have blockbuster potential. The PCSK9 protein -- short for proprotein convertase subtilisin/kexin type 9 -- is responsible for breaking down the LDL receptor that removes bad LDL cholesterol from the blood.

    Comment?

  3. Glass in Cholesterol Drug Caused Injury, Man SaysRead the original story

    Oct 6, 2014 | Courthouse News Service

    Microscopic pieces of glass in the generic version of a cholesterol drug subject to a federal recall cut up a Delaware man's urinary tract, he claims in court. The Oct. 1 complaint filed in the Philadelphia Court of Common Pleas alleges that Calvin Johnson had a kidney stone and blood in his urine after taking atorvastatin, the generic version of Lipitor manufactured by Ranbaxy Pharmaceuticals.

    Comment?

  4. Atorvastatin Inhibits gp91phox Circulating Levels in Patients With HypercholesterolemiaRead the original story

    Feb 1, 2010 | Circulation

    From the Department of Experimental Medicine , "Sapienza" University; Department of Internal Medicine , University of Rome "Tor Vergata"; and Department of Clinical and Medical Therapy , "Sapienza" University, Rome, Italy. Correspondence to Prof Francesco Violi, Department of Experimental Medicine, Divisione I Clinica Medica, "Sapienza" University, Rome, Italy, Viale del Policlinico 155, Roma, 00161, Italy.

    Comment?

  5. UPDATE 1-Esperion drug succeeds in lowering LDL cholesterol -studyRead the original story

    Oct 1, 2014 | Reuters

    An experimental cholesterol-fighting drug being developed by Esperion Therapeutics Inc lowered LDL levels significantly more than Merck & Co Inc's Zetia in a midstage clinical trial, Esperion said on Wednesday. In a 12-week study involving 348 patients with high LDL cholesterol, the Esperion drug, ETC-1002, led to an average 30 percent reduction in levels of the "bad" cholesterol for those who received a 180 milligram dose and a 27 percent reduction with a 120 mg dose, according to initial results.

    Comment?

  6. Esperion drug succeeds in lowering LDL cholesterol -studyRead the original story

    Oct 1, 2014 | Reuters

    A new type of experimental cholesterol fighter being developed by Esperion Therapeutics Inc lowered LDL levels significantly more than Merck & Co Inc's Zetia in a midstage clinical trial, the company said on Wednesday. In the 12-week study involving 348 patients with high LDL cholesterol the Esperion drug, ETC-1002, led to an average 30 percent reduction in levels of the "bad" cholesterol for those who received a 180 milligram dose and a 27 percent reduction with a 120 mg dose, according to initial results.

    Comment?

  7. Americans, I have some bad news for youRead the original story w/Photo

    Sep 30, 2014 | Ukiah Blog Live

    If you had any idea of how people really lived in Western Europe, Australia, New Zealand, Canada and many parts of Asia, you'd be rioting in the streets calling for a better life. In fact, the average Australian or Singaporean taxi driver has a much better standard of living than the typical American white-collar worker.

    Comment?

  8. Bronx Cardiologist Prescribes Vegan Diet to Improve Your Sex LifeRead the original story w/Photo

    Sep 29, 2014 | DNAinfo.com

    If you want to mend your ailing heart - or fix your sex life - one doctor says you should try going vegan. Bronx cardiologist Dr. Robert Ostfeld is promoting a whole-food plant-based diet to help prevent heart disease and other illnesses, including diabetes, hypertension and even sexual dysfunction.

    Comment?

  9. As Lipitor Lawsuits Move Forward, Bernstein Liebhard LLP Notes New...Read the original story w/Photo

    Sep 26, 2014 | PRWeb

    The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes allegedly due to their use of the statin medication. The publication of this study comes as hundreds of plaintiffs in the U.S. pursue Lipitor lawsuits that allege the use of this statin increased their risk for diabetes.

    Comment?

  10. Sovaldi's High Price Reflects a Trend, Not an Exception to the RuleRead the original story

    Sep 26, 2014 | P&T Community

    The hepatitis C drug Sovaldi burst onto the market in December 2013, impressing doctors and patients with its benefits and outraging payers and politicians with its price. The drug reached blockbuster status twice over in the course of a single quarter.

    Comment?

  11. In re Lipitor Antitrust LitigationRead the original story w/Photo

    Sep 25, 2014 | JD Supra

    In the lastest instance of a plaintiff attempting to extend the Supreme Court's holding in FTC v. Actavis that "reverse payment" settlement agreements in ANDA litigation could be anticompetitive and violate the antitrust laws, the District Court of New Jersey granted defendants' motion to dismiss under Fed.

    Comment?

  12. Lipitor Lawsuit News: New Case Management Order Issued in Federal...Read the original story

    Sep 24, 2014 | Personal Injury Law News

    The Firm is evaluating potential Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to their use of the cholesterol-lowering statin.

    Comment?

  13. Some Men Reject Blood-Pressure and Cholesterol-Lowering Drugs Because They Affect Their Sex LivesRead the original story w/Photo

    Sep 24, 2014 | Weekend

    Robert A. Winn, M.D., a Chicago-based physician, said that since 1990, 25 to 33 percent of his male patients who suffered from high blood pressure or high cholesterol, refused to take prescribed medications to treat these ailments because they affected their sexual performance. "The patients said when they took these medicines they lost a part of themselves because they could no longer have sex," said Dr. Winn, who is associate vice president of community-based practice at UI , which oversees Mile Square Health Center on Chicago's West side.

    Comment?

  14. Lowell cracking down on problem propertiesRead the original story w/Photo

    Sep 24, 2014 | Lowell Sun

    By the end of the day Tuesday, Pedro Garcia Cardona and his 9-year-old son had no place to come home to. City inspectors, fire and police officials swarmed into the home on 15 Grand St., which police identified as a "problem property" where alleged drug dealing and other disturbances take place.

    Comment?

  15. Research and Markets: Crestor (rosuvasta ...Read the original story

    Sep 24, 2014 | The Financial Mirror

    Research and Markets: Crestor for Acute Coronary Syndrome - Forecast and Market Analysis to 2023: Patent Expires in 2016 in the US and 2017 in the EU and Japan The current ACS market - primarily comprised of antithrombotics, antihypertensives, and statins - is flush with well-established standard-of-care therapies, many of which are generic. Therefore, the pipeline therapies that show the most promise exploit novel mechanisms of action and target orphan biochemical pathways.

    Comment?

  16. Statin users more at risk of piling on the pounds: Scientists warn ...Read the original story w/Photo

    Sep 23, 2014 | Daily Mail

    British scientists have warned that the millions who are given the cholesterol-busting drugs should also be advised to do more exercise in a bid to counter the unwanted side effect. The discovery, made by researchers at University College London and the University of Glasgow, will add fuel to the controversy raging over the use of statins.

    Comment?

  17. Statins Double Stroke Victims' Survival Chances: StudyRead the original story w/Photo

    Sep 23, 2014 | News Max

    Cholesterol-lowering statins such as Pfizer Inc.'s Lipitor helped boost survival in patients who had a stroke caused by bleeding in the brain, a study from Hemorrhagic stroke patients given a statin while in the hospital had about double the chance of survival compared to those not given the drugs, according to research today in the journal . Those already taking the drugs and who stayed on them in the hospital were three times more likely to survive after a stroke than those whose medicine was stopped.

    Comment?

  18. Orchid Chemicals & Pharmaceuticals Ltd (ORCHIDCHEM) - Pharmaceuticals ...Read the original story

    Sep 20, 2014 | PR-inside.com

    The company develops and manufactures formulations and APIs. Its formulations include amlodipine besilate and atenolol tablets, losartan potassium with hydrochlorothiazide, amlodipine besilate and atenolol tablets, losartan potassium tablets, olmesartan medoxomil tablets, clopidogrel tablets USP, glimipride tablets, duloxetin tablets, methylcobalamin injection, voriconazole, atorvastatin and fenofibrate tablets.

    Comment?

  19. Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal...Read the original story w/Photo

    Sep 19, 2014 | PRWeb

    The Firm is evaluating Lipitor lawsuits on behalf of individuals who developed Type 2 diabetes, allegedly due to their use of the statin medication. Our Firm continues to hear from Lipitor patients who allegedly developed diabetes due to this medication.

    Comment?

  20. AMRIC begins clinical trial for heart disease and strokeRead the original story w/Photo

    Sep 19, 2014 | Northern Life

    Dr. Francisco Diaz-Mitoma, CEO and chief scientific director of the Advanced Medical Research Institute of Canada, says a new clinical trial in Sudbury could change the way doctors treat heart disease. File photo.

    Comment?